• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

mantle cell lymphoma (MCL) - Articles and news items

EC approves Revlimid for mantle cell lymphoma

Industry news / 15 July 2016 / Victoria White, Digital Content Producer

Celgene’s Revlimid (lenalidomide) has been approved by the EC for the treatment of adult patients with relapsed or refractory mantle cell lymphoma…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +